IMAGE CREDITS: COREWIRE / AI ILLUSTRATION

Two secret filings, one loud question

OpenAI and Anthropic file S-1s a week apart, the bubble evidence scored, and the three-day product retreat.

Two AI labs filed for IPOs in secret, a week apart. Everything else this week, the bubble arguments, the product retreats, the default switches, is downstream of what those filings mean. Start there.

Two envelopes, one week

OpenAI and Anthropic both confidentially submitted draft S-1s in June. What each company has actually confirmed versus what the press repeats is a shorter list than you think. Confirmed vs speculation →

OpenAI and Anthropic IPO watch

The question the filings force

Public markets will finally price the question everyone argues about at dinner: is this a bubble? The revenue is real and compounding. The valuations price perfection. Both things are true, and we scored the evidence on each side. Weigh it yourself →

AI bubble evidence both sides

The mood in one product decision

Want the market’s temperature without a terminal? Meta launched an image feature, met CAA and SAG-AFTRA, and killed it in three days. Confidence does not retreat that fast. The 72-hour story →

Meanwhile, the quiet strategy

Away from the drama, Anthropic switched millions of users to Sonnet 5 by default. Nobody chose it, everybody got it, and that is precisely the point. Defaults, not demos, decide market share. Why defaults win →

Even the design tools picked a side

And in the application layer, Figma put code directly on the design canvas. The wall between designing software and building it is coming down in public. What Config changed →

One number

Three days. Launch to retreat for Meta’s Muse @-mentions. The fastest product reversal of the AI era so far. What happened →

One thing to use

The Corewire resource shelf. Our explainers, guides and free tools in one place, built for exactly these arguments. Browse it →

That is the thread: the labs headed for the public markets, and every product decision this week made sense as positioning for that moment. Hit reply with your IPO prediction; I will keep score. Forwarded this? Claim your own copy.

Dr. Joseph Joshua

P.S. If The Signal has earned your inbox, forward it to one person who argues about AI at dinner. That is how this grows.

Get the Signal

AI and business tech news, verified by a physician who reads the filings. One email a week, no noise.

Dr. Joseph Joshua

Dr. Joseph Joshua is the founder and editor of Corewire. A medical doctor by training, he brings the evidence-first discipline of clinical medicine to technology journalism: claims get checked against primary sources before they get published. He has produced technology and B2B content for companies across…

View Bio

Keep Reading